Spectrum Pharmaceuticals (SPPI) PT Raised to $13 at Jefferies
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Jefferies analyst Matthew Andrews raised his price target on Spectrum Pharmaceuticals (NASDAQ: SPPI) to $13.00 (from $9.00) while maintaining a Buy rating.
Andrews notes its under the radar NSCLS drug Poziontinib to be a highlighted at World Lung Congress.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- Macquarie Upgrades ASM Pacific Technology (522:HK) (ASMVY) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Hot CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
